A Study to Evaluate Crovalimab in People With Antiphospholipid Syndrome (APS)

Clinical trial NCT07172022 · WITHDRAWN

Trial details

NCT number: NCT07172022
Sponsor: Hoffmann-La Roche
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Antiphospholipid Syndrome

Start date: 2026-03-16
Primary completion: 2030-03-11
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.